Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
See the Price Targets and Ratings of:
PRLD Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$5
Buy
104.08%
Upside
Reiterated
09/23/25
Prelude Therapeutics: Promising SMARCA2-Targeted Degraders and Positive Outlook Support Buy RatingValuation and Risks. We use a discounted cash flow (DCF)-based approach, which employs an 11% discount rate and a 2% terminal growth rate. We ascribe a 15% probability of approval to PRT3789. Our effective tax rate is 29.7%.
Citizens JMP
$4→$3
Buy
22.45%
Upside
Reiterated
08/18/25
Barclays
$1
Sell
-59.18%
Downside
Reiterated
05/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$5
Buy
104.08%
Upside
Reiterated
09/23/25
Prelude Therapeutics: Promising SMARCA2-Targeted Degraders and Positive Outlook Support Buy RatingValuation and Risks. We use a discounted cash flow (DCF)-based approach, which employs an 11% discount rate and a 2% terminal growth rate. We ascribe a 15% probability of approval to PRT3789. Our effective tax rate is 29.7%.
Citizens JMP
$4→$3
Buy
22.45%
Upside
Reiterated
08/18/25
Barclays
$1
Sell
-59.18%
Downside
Reiterated
05/07/25
Best Analysts Covering Prelude Therapeutics
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
-7.17%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of -7.17% per trade.
3 Months
xxx
Success Rate
5/11 ratings generated profit
Average Return
-0.13%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of -0.13% per trade.
1 Year
Success Rate
5/11 ratings generated profit
Average Return
+17.78%
reiterated a buy rating 4 months ago
Copying Reni Benjamin's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +17.78% per trade.
2 Years
xxx
Success Rate
6/11 ratings generated profit
Average Return
+46.82%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 54.55% of your transactions generating a profit, with an average return of +46.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRLD Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Aug 25
Sep 25
Strong Buy
3
4
5
5
3
Buy
0
0
0
0
0
Hold
2
2
0
0
0
Sell
4
2
3
1
1
Strong Sell
0
0
0
0
0
total
9
8
8
6
4
Each month's total comprises the sum of three months' worth of ratings.
PRLD Stock Forecast FAQ
What is PRLD’s average 12-month price target, according to analysts?
Currently, no data Available
What is PRLD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for PRLD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRLD a Buy, Sell or Hold?
Prelude Therapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Prelude Therapeutics’s price target?
Currently, no data Available
What do analysts say about Prelude Therapeutics?
Prelude Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of PRLD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.